Skip to content

Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy

Esketamine Combined With Magnesium Sulfate for Postoperative Fatigue Syndrome in Patients Undergoing Laparoscopic Cholecystectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109385
Enrollment
Unknown
Registered
2025-09-17
Start date
2025-09-20
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

In recent years, laparoscopic cholecystectomy (LC) has been widely adopted due to its minimal invasiveness and faster recovery. However, CO2 pneumoperitoneum during surgery induces significant physiological changes: increased abdominal pressure reduces venous return and cardiac output, while sympathetic activation elevates catecholamine release, blood pressure, and vascular resistance. Concurrentl

Interventions

intravenous saline group:Intravenous pump infusion of normal saline
intravenous esketamine group:Intravenous pump infusion of esketamine
intravenous maegmnesium group:Intravenous pump infusion of esketamine
intravenous esketamine and maegmnesium group:Intravenous pump infusion of esketamine + magnesium sulfate

Sponsors

The Second People’s Hospital of Huai’an
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 65 years; 2.American Society of Anesthesiologists (ASA) classification I-II; 3.Patients scheduled for LC under general anaesthesia and with a procedure duration of less than 60 minutes.

Exclusion criteria

Exclusion criteria: 1.Patients who do not sign the informed consent; 2.patients with severe diseases of major organs such as the heart, brain, lungs, liver, and kidneys; 3.patients with adverse drug reactions to esketamine or magnesium sulfate; 4.patients with uncontrolled hypertension or hyperthyroidism; 5.patients with endocrine and metabolic diseases or neurological diseases; 6.pregnant or lactating women; 7.long-term users of sedatives, analgesics, or long-term alcohol abusers; 8.patients with a history of mental illness, language communication barriers, or inability to understand the content of the experiment; 9.patients with difficult airways during anesthesia induction requiring a change in the conventional intubation method; 10.patients with sinus bradycardia or atrioventricular block; 11.patients with concurrent cholangitis, biliary obstruction, or pancreatitis.

Design outcomes

Primary

MeasureTime frame
Christensen's Fatigue Scale?Identity-Consequence Fatigue Scale;

Secondary

MeasureTime frame
Sleep data;perioperative hemodynamic fluctuations;The Quality of Recovery-15?Numeric Rating Scale?Richmond Agitation and Sedation Scale;intraoperative vasoactive drug and narcotic drug dosage;

Countries

China

Contacts

Public ContactJie Chenglan

The Second People’s Hospital of Huai’an

xiechenglan@163.com+86 517 80871603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026